Prelude Capital Management’s Xeris Biopharma Holdings XERS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$72.4K	Buy	+15,500	New	+$72.4K	0.01%	934
2020 Q4	–	Hold	0	–	–	–	1623
2020 Q3	–	Hold	0	–	–	–	1910
2019 Q3	–	Sell	-757	Closed	-$9K	–	1636
2019 Q2	$9K	Buy	+757	New	+$9K	﹤0.01%	1040